Tag: biomedical
-

Small Biz Grant Funds Long-Term Spasticity Implant
A developer of treatments for neurological disorders received National Institutes of Health funding for an implant treating spasticity for up to six months.
-

New Company to Develop Synthetic Antibody Therapies
A new business is underway to develop and commercialize treatments for Covid-19 and other diseases based on synthetic antibody proteins.
-

Infographic – Unvaccinated Driving New Covid-19 Cases
Data released by the U.S. Centers for Disease Control and Prevention show new Covid-19 infections are concentrated largely among unvaccinated people.
-

Targeted Immunotherapy Shown to Shrink, Stop Tumors
Results from tests with lab mice show an experimental targeted cancer therapy invoking the immune system shrinks tumors and prevents their recurrence.
-

Trial Identifies Biomarkers for Quick Concussion Test
A clinical trial reveals glycan compounds found in saliva and urine as indicators of traumatic brain injury, helping create a quick diagnostic for the condition.
-

Trial Shows Psilocybin Drug Helps Reduce Depression
A clinical trial shows a drug derived from the hallucinogenic compound psilocybin reduces symptoms of depression, when part of a therapy program.
-

Chip Device Simulates Coronavirus Gut Symptoms
Biomedical engineers found a chip device with intestinal tissue can simulate coronavirus infections and symptoms in the gut, and test possible treatments.
-

Joint Venture to Develop Stable RNA Covid-19 Vaccine
A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine.
-

Alphabet Forms AI Drug Discovery Company
Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs.
-

Cell Therapy Biotech Raises $75.5M in Venture Funds
A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round.